Medicare Enrolled
Dr. Iqra Choudary, MD
Hematology & Oncology · Auburn, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Choudary from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Choudary?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Choudary
Dr. Iqra Choudary is a hematology & oncology specialist in Auburn, NY, with 14 years of NPI registration. Based on federal Medicare data, Dr. Choudary performed 98,700 Medicare services across 3,767 unique beneficiaries.
Between the years covered by Open Payments, Dr. Choudary received a total of $4,420 from 27 pharmaceutical and/or device companies across 78 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Choudary is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years in practice
▲ Top 6% volume in NY
$4,420 industry payments
Medicare Practice Summary
Medicare Utilization ↗98,700
Medicare services
Top 6% in NY for hematology & oncology
3,767
Unique beneficiaries
$4
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7,050 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
56,250 | $1 | $4 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
20,820 | $2 | $10 |
| Anti-nausea injection (aprepitant) | 6,760 | $1 | $8 |
| Denosumab injection (Prolia/Xgeva) | 5,100 | $18 | $42 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,269 | $8 | $20 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,129 | $8 | $23 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
976 | $10 | $31 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
822 | $0 | $1 |
| Anti-nausea injection (Aloxi/palonosetron) | 550 | $1 | $38 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
525 | $93 | $220 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
349 | $13 | $39 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
330 | $12 | $60 |
| Iron level test | 329 | $6 | $19 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
329 | $9 | $25 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
295 | $9 | $27 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
274 | $15 | $42 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
263 | $11 | $65 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
262 | $61 | $148 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
245 | $134 | $297 |
| Reticulated platelet measurement A blood test that measures the level of young, newly formed platelets in the body. |
163 | $35 | $77 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
141 | $6 | $19 |
| Manual white blood cell count A laboratory test that involves examining a sample under a microscope to manually count the number of white blood cells present. |
138 | $4 | $10 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
123 | $99 | $361 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
104 | $14 | $39 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
103 | $48 | $183 |
| Serum protein measurement A blood test that measures the total amount of protein in the serum. It helps evaluate overall health and nutritional status. |
97 | $10 | $30 |
| Serum immunofixation test A laboratory test that analyzes a blood serum sample to identify specific abnormal proteins. The procedure uses an immunologic technique to detect and characterize these proteins. |
94 | $22 | $62 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
92 | $4 | $12 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
91 | $1 | $2 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
82 | $21 | $77 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
63 | $16 | $49 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
60 | $1 | $10 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
55 | $6 | $18 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
45 | $42 | $150 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
45 | $120 | $337 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
44 | $49 | $174 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
39 | $1 | $5 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
36 | $61 | $150 |
| New patient office visit, complex (60-74 min) | 30 | $168 | $423 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
27 | $5 | $16 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
20 | $4 | $8 |
| Urine volume measurement | 19 | $4 | $9 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
19 | $99 | $283 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
19 | $91 | $215 |
| Coagulation assessment blood test A blood test that measures how long it takes for blood to clot. The sample can be plasma or whole blood. |
17 | $6 | $35 |
| Automated platelet count test A laboratory test that uses a machine to count the number of platelets in a blood sample. Platelets are blood cells that help the body form clots to stop bleeding. |
16 | $4 | $16 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
16 | $75 | $221 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
14 | $7 | $20 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
11 | $133 | $419 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
57.3% high complexity
35.3% medium
7.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,420
Total received (2018-2024)
Avg $631/year across 7 years
Top 36% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
78
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$3,106 (70.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,314 (29.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,603
2023
$230
2022
$216
2021
$310
2020
$185
2019
$504
2018
$372
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Pharmacosmos Therapeutics Inc.
$2,483
Genmab U.S., Inc.
$101
Tempus AI, Inc
$19
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Pharmacosmos Therapeutics Inc.
$2,483
Lilly USA, LLC
$232
E.R. Squibb & Sons, L.L.C.
$202
BeiGene USA, Inc.
$150
PFIZER INC.
$140
Amgen Inc.
$135
Pharmacyclics LLC, An AbbVie Company
$123
Janssen Biotech, Inc.
$108
Genmab U.S., Inc.
$101
Seagen Inc.
$100
Incyte Corporation
$100
Novartis Pharmaceuticals Corporation
$93
Celgene Corporation
$71
Puma Biotechnology, Inc.
$59
Merck Sharp & Dohme Corporation
$54
Seattle Genetics, Inc.
$39
AstraZeneca Pharmaceuticals LP
$37
Exelixis Inc.
$36
Bayer HealthCare Pharmaceuticals Inc.
$21
Genentech USA, Inc.
$20
GENZYME CORPORATION
$20
Tempus AI, Inc
$19
Teva Pharmaceuticals USA, Inc.
$18
AbbVie, Inc.
$17
Clovis Oncology, Inc.
$15
Foundation Medicine, Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$14
Top 3 companies account for 66.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALIMTA · Abraxane · BENDEKA · BOSULIF · BRUKINSA · Cabometyx · DARZALEX · EMPLICITI · Epkinly · Erleada · FOUNDATIONONE · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · Imbruvica · KEYTRUDA · KISQALI · LYNPARZA · Lupron Depot · MEKINIST · MONOFERRIC · MYLOTARG · Nerlynx · Neulasta · Nplate · Nubeqa · OPDIVO · PROMACTA · RETEVMO · Revlimid · Rubraca · SIMPONI ARIA · TAGRISSO · TUMOR LYSIS SYNDROME - DISEASE · XTANDI
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Hematology & oncology specialists within 10 mi
21
Per 100K population
27.8
County median income
$66,583
Nearest hospital
AUBURN COMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Choudary is a mixed practice specialist, with above-average Medicare volume (top 6% in NY), with speaking/promotional industry engagement.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Choudary experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Choudary performed 56,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Choudary receive payments from pharmaceutical companies?
Yes. Dr. Choudary received a total of $4,420 from 27 companies across 78 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Choudary's costs compare to other hematology & oncology specialists in Auburn?
Dr. Choudary's average Medicare payment per service is $4. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Choudary) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Auburn
Browse hematology & oncology specialists in Auburn ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
Pharmacosmos Therapeutics Inc. Payments to Doctors
See all physicians who received payments from Pharmacosmos Therapeutics Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology